Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)

Market Cap	5.50B
Revenue (ttm)	2.05B
Net Income (ttm)	226.39M
Shares Out	1.19B
EPS (ttm)	0.20
PE Ratio	23.42
Forward PE	n/a
Dividend	0.05 (1.08%)
Ex-Dividend Date	May 28, 2025

Volume	43,579,721
Average Volume	37,032,223
Open	4.610
Previous Close	4.640
Day's Range	4.600 - 4.720
52-Week Range	3.650 - 5.680
Beta	0.34
RSI	63.21
Earnings Date	Aug 27, 2025

About SHE:300194

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the People's Republic of...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 3,392
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300194

Financial Performance

In 2024, SHE:300194's revenue was 2.39 billion, a decrease of -9.68% compared to the previous year's 2.65 billion. Earnings were 279.84 million, an increase of 20.69%.